UnitedHealth Group
GenAI for Medicare Part D
- Challenge
- Identify the highest-impact drugs to inform the Medicare Part D bidding process.
- Approach
- Embedded with business teams, owning strategy, product, architecture and hands-on engineering of an evidence-based GenAI solution.
3 weeks
from idea to MVP; now being taken to production

















